The era of prostate-specific membrane antigen (PSMA)-based theranostics for hepatocellular carcinoma is upcoming: are we ready for it?
- PMID: 35947176
- DOI: 10.1007/s00259-022-05928-0
The era of prostate-specific membrane antigen (PSMA)-based theranostics for hepatocellular carcinoma is upcoming: are we ready for it?
Comment on
-
PET imaging of hepatocellular carcinoma by targeting tumor-associated endothelium using [68Ga]Ga-PSMA-617.Eur J Nucl Med Mol Imaging. 2022 Oct;49(12):4000-4013. doi: 10.1007/s00259-022-05884-9. Epub 2022 Jun 28. Eur J Nucl Med Mol Imaging. 2022. PMID: 35763056 Free PMC article.
References
-
- Lu Q, Long Y, Fan K, Shen Z, Gai Y, Liu Q, et al. PET imaging of hepatocellular carcinoma by targeting tumor-associated endothelium using [68Ga]Ga-PSMA-617. Eur J Nucl Med Mol Imaging. 2022. https://doi.org/10.1007/s00259-022-05884-9 . - DOI - PubMed - PMC
-
- Zhang C, Cheng Y, Zhang S, Fan J, Gao Q. Changing epidemiology of hepatocellular carcinoma in Asia. Liver Int. 2022. https://doi.org/10.1111/liv.15251 . - DOI - PubMed
-
- Chen J, Xiong P, Nie M, Pan Y, Wang J, Hu D, et al. The combination treatment strategy of lenvatinib for hepatocellular carcinoma: a real-world study. J Cancer Res Clin Oncol. 2022. https://doi.org/10.1007/s00432-022-04082-2 . - DOI - PubMed - PMC
-
- Abdelrahim M, Esmail A, Umoru G, Westhart K, Abudayyeh A, Saharia A, et al. Immunotherapy as a neoadjuvant therapy for a patient with hepatocellular carcinoma in the pretransplant setting: a case report. Curr Oncol. 2022;29:4267–73. - DOI
-
- Dondi F, Albano D, Cerudelli E, Gazzilli M, Giubbini R, Treglia G, et al. Radiolabelled PSMA PET/CT or PET/MRI in hepatocellular carcinoma (HCC): a systematic review. Clin Transl Imaging. 2020;8:461–7. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous